J07BB02 · Anti-infectives for systemic use
Zoonotic Influenza Vaccine Seqirus
Indications
Zoonotic Influenza Vaccine Seqirus H5N8 is indicated for active immunisation against H5 subtype influenza A viruses in individuals 6 months of age and above. The use of this vaccine should be in accordance with official recommendations.
Composition
- Active substance
- A/Astrakhan/3212/2020 (H5N8)-like strain (CBER-RG8A) (clade 2.3.4.4b)
- International name (INN)
- zoonotic influenza vaccine (H5N8) (surface antigen, inactivated, adjuvanted)
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Zoonotic Influenza Vaccine Seqirus
- Active substance
- A/Astrakhan/3212/2020 (H5N8)-like strain (CBER-RG8A) (clade 2.3.4.4b)
- ATC code
- J07BB02